DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METRONIDAZOLE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Metronidazole Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00002682	Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach	Completed	National Cancer Institute (NCI)	Phase 2	RATIONALE: Antibiotic therapy and antacids are used to treat Helicobacter pylori infection of the stomach. These treatments may also have an effect on gastric MALT lymphoma of the stomach. PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy with amoxicillin, clarithromycin, tetracycline, and metronidazole plus antacids in patients with MALT lymphoma of the stomach.
NCT00002682	Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach	Completed	M.D. Anderson Cancer Center	Phase 2	RATIONALE: Antibiotic therapy and antacids are used to treat Helicobacter pylori infection of the stomach. These treatments may also have an effect on gastric MALT lymphoma of the stomach. PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy with amoxicillin, clarithromycin, tetracycline, and metronidazole plus antacids in patients with MALT lymphoma of the stomach.
NCT00003151	Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma	Completed	University of Glasgow	Phase 2	RATIONALE: Antibiotics may stop the growth of Helicobacter pylori which may be associated with gastric lymphoma. PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy in treating patients with low grade gastric lymphoma that has not been previously treated.
NCT00003151	Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma	Completed	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2	RATIONALE: Antibiotics may stop the growth of Helicobacter pylori which may be associated with gastric lymphoma. PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy in treating patients with low grade gastric lymphoma that has not been previously treated.

Clinical Trial Conditions for Metronidazole Hydrochloride

Condition Name

Condition Name for Metronidazole Hydrochloride
Intervention	Trials
Helicobacter Pylori Infection	43
Bacterial Vaginosis	33
Chronic Periodontitis	10
Appendicitis	8

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Metronidazole Hydrochloride
Intervention	Trials
Infection	75
Helicobacter Infections	59
Communicable Diseases	55
Vaginosis, Bacterial	41

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Metronidazole Hydrochloride

Trials by Country

Trials by Country for Metronidazole Hydrochloride
Location	Trials
United States	423
Canada	32
Taiwan	32
China	25
Japan	22

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Metronidazole Hydrochloride
Location	Trials
Texas	28
California	27
Pennsylvania	22
North Carolina	21
Florida	20

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Metronidazole Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Metronidazole Hydrochloride
Clinical Trial Phase	Trials
Phase 4	123
Phase 3	69
Phase 2/Phase 3	14

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Metronidazole Hydrochloride
Clinical Trial Phase	Trials
Completed	158
Recruiting	83
Not yet recruiting	34

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Metronidazole Hydrochloride

Sponsor Name

Sponsor Name for Metronidazole Hydrochloride
Sponsor	Trials
National Taiwan University Hospital	15
National Institute of Allergy and Infectious Diseases (NIAID)	11
Shanghai Jiao Tong University School of Medicine	7

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Metronidazole Hydrochloride
Sponsor	Trials
Other	373
Industry	111
NIH	19

Export unavailable in trial.
Subscribe for complete access.